Cargando…

FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling

BACKGROUND: FAT4, a cadherin-related protein, was shown to function as a tumour suppressor; however, its role in human gastric cancer remains largely unknown. Here, we investigated the role of FAT4 in gastric cancer and examined the underlying molecular mechanisms. METHODS: The expression of FAT4 wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Jian, Feng, Dan, Hu, Liang, Chen, Haiyang, Yang, Guangzhen, Cai, Qingping, Gao, Chunfang, Wei, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701992/ https://www.ncbi.nlm.nih.gov/pubmed/26633557 http://dx.doi.org/10.1038/bjc.2015.367

Ejemplares similares

The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs)
por: Rogers, H A, et al.
Publicado: (2013)

Wnt–β-catenin–Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer
por: Ravindranath, A, et al.
Publicado: (2011)

WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma
por: Rogers, H A, et al.
Publicado: (2012)

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
por: Noda, T, et al.
Publicado: (2009)

Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours
por: Wang, Y, et al.
Publicado: (2006)

The expression of tumour suppressors and proto-oncogenes in tissues susceptible to their hereditary cancers
por: Muir, Brian, et al.
Publicado: (2015)

RNA helicase DHX15 acts as a tumour suppressor in glioma
por: Ito, Shingo, et al.
Publicado: (2017)

The tumour suppressor miR-34c targets MET in prostate cancer cells
por: Hagman, Z, et al.
Publicado: (2013)

The von Hippel–Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform
por: Chesnel, F, et al.
Publicado: (2015)

Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer
por: Amir, Sumaira, et al.
Publicado: (2016)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role
por: Bullock, M D, et al.
Publicado: (2013)

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients
por: Avgeris, M, et al.
Publicado: (2013)

Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver adenomas
por: Singh, Y, et al.
Publicado: (2014)

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis
por: Turato, C, et al.
Publicado: (2014)

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
por: White, N M A, et al.
Publicado: (2011)

Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma
por: Aigelsreiter, A, et al.
Publicado: (2013)

WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways
por: Ji, Jiafu, et al.
Publicado: (2015)

An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET)
por: Rogers, H A, et al.
Publicado: (2009)

Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
por: Lee, H E, et al.
Publicado: (2008)

Securin (hPTTG1) expression is regulated by β-catenin/TCF in human colorectal carcinoma
por: Hlubek, F, et al.
Publicado: (2006)

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
por: Chiyomaru, T, et al.
Publicado: (2010)

miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
por: Higashi, T, et al.
Publicado: (2015)

High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment
por: Ma, G-F, et al.
Publicado: (2014)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

Role of multifunctional transcription factor TFII-I and putative tumour suppressor DBC1 in cell cycle and DNA double strand damage repair
por: Tanikawa, M, et al.
Publicado: (2013)

β-Catenin is involved in alterations in mitochondrial activity in non-transformed intestinal epithelial and colon cancer cells
por: Mezhybovska, M, et al.
Publicado: (2009)

Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer
por: Tokumoto, Mao Watanabe, et al.
Publicado: (2015)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma
por: Ueno, K, et al.
Publicado: (2011)

ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines
por: Khursheed, M, et al.
Publicado: (2013)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer
por: Kaneda, H, et al.
Publicado: (2011)

Tropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer
por: Tanaka, K, et al.
Publicado: (2014)

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management
por: Dômont, J, et al.
Publicado: (2010)

Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours
por: Skliris, G P, et al.
Publicado: (2006)

Hypoxia triggers a Nur77–β-catenin feed-forward loop to promote the invasive growth of colon cancer cells
por: To, S K Y, et al.
Publicado: (2014)

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
por: Xu, Y, et al.
Publicado: (2012)

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
por: Akiyoshi, S, et al.
Publicado: (2012)

Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an αvβ3-independent manner
por: Edwards, S, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_pvd10epv4r12mfvibiugjlfqg6